Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-16

Clinical Trial Update: A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder [Phase 4]

View source ↗

Summary

A Phase 4 randomized controlled trial is examining N-acetylcysteine for the management of Alcohol Use Disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Sydney | Conditions: Alcohol Use Disorder (AUD) | Phase 4 | Status: RECRUITING